“The null effect of fenofibrate on plasma ADMA levels is in line with reported effects of other lipid-lowering agents (HMG-CoA-reductase inhibitors), but fenofibrate treatment elevated the plasma L-arginine :ADMA ratio, suggesting an improvement of endogenous NO formation and endothelial function.”